Treatment Registry
TR-0840 ActiveRecorded September 13, 2026

Compounded tirzepatide

Sold by Edessa · Injection, vial · every compounded tirzepatide record

What you actually pay

Per month

$239

Medication · 1 month$239

Added from the figures recorded below.

Price

TermPer monthCharged today
1 monthAdvertised

Plan Per Month 6 Month Best Value $209 3 Month $219 1 Month $239

source

Per month$239Charged today$239
3 month plan, billed monthly

Plan Per Month 6 Month Best Value $209 3 Month $219 1 Month $239

source

Per month$219Charged today$219
6 month plan, billed monthly

Plan Per Month 6 Month Best Value $209 3 Month $219 1 Month $239

source

Per month$209Charged today$209
Visit Edessa

We earn nothing from this link. Edessa has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 13, 2026Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberAsynchronous review
Cancellation“There's no commitment or hidden charges.”
MembershipNone. “The Edessa Tirzepatide program is as low as $209 per month with no contract. This cost covers your physician review, full personalized plan, 1-on-1 guidance, and the cost of the prescription medication shipped right to your door.”
Consult feeNone. “The Edessa Tirzepatide program is as low as $209 per month with no contract. This cost covers your physician review, full personalized plan, 1-on-1 guidance, and the cost of the prescription medication shipped right to your door.”

Recorded from myedessa.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 13, 2026Edessa's plan tables are headed “Per Month” and state no day-one total, so the multi-month tiers are recorded as billed monthly rather than prepaid — its own FAQ says the program is “as low as $135 for your first month with no contract” and that “Refills are as low as $135 per month … There's no commitment or hidden charges.” No upfront figure is multiplied out here, because Edessa publishes none. Clinical review is described as being performed by OpenLoop Health; the dispensing pharmacy is not named, the site saying only that “We are partnered with multiple USA certified pharmacies”.

1 further note concerns other Edessa programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0840
Readings
1

Related records

What else Edessa sells

All Edessa programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Edessa compounded tirzepatide (TR-0840). Last verified September 13, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0840

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.